Bone metastasis is a common complication of prostate cancer and is associated with significant morbidity for patients. Bone metabolism and prostate cancer metastasis to bone are complex processes. The interactions between host cells and metastatic prostate cancer cells are important components of organ-specific cancer progression. In addition to traditional treatment approaches, targeted therapy is currently becoming more popular. Bone metabolism, metastatic processes of prostate cancer, and the targeting of treatment for advanced disease are discussed here. Copyright © 2007 by Current Medicine Group LLC
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone heal...
Cancer is a major leading cause of death in the western world (following heart diseases). It poses a...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
Bone is the most common site for metastasis in human prostate cancer patients. Skeletal metastases a...
Bone is one of the most preferential target site for cancer metastases, particularly for prostate, b...
Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone heal...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone heal...
Cancer is a major leading cause of death in the western world (following heart diseases). It poses a...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
Metastatic bone disease (MBD) in advanced-stage cancer increases the risk of intractable bone pain, ...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
Bone is the most common site for metastasis in human prostate cancer patients. Skeletal metastases a...
Bone is one of the most preferential target site for cancer metastases, particularly for prostate, b...
Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone heal...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone heal...
Cancer is a major leading cause of death in the western world (following heart diseases). It poses a...